SIA GriPharmaActive
Key figures
Ratios
2025Balance sheet structure
Dividends
calculatedNo dividends were paid.
Summary of financial statements2015–2025
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance sheet — assets | |||||||||||
| Total current assets | 42 938 | 46 701 | 116 074 | 121 920 | 94 744 | 93 695 | 129 013 | 217 113 | 250 080 | 73 146 | 5756 |
| Total non-current assets | 0 | 0 | 23 665 | 18 867 | 14 067 | 9267 | 4467 | 35 300 | 47 524 | 50 961 | 31 739 |
| Total assets | 42 938 | 46 701 | 139 739 | 140 787 | 108 811 | 102 962 | 133 480 | 252 413 | 297 604 | 124 107 | 37 495 |
| Balance sheet — liabilities and equity | |||||||||||
| Current liabilities | 25 271 | 20 978 | 98 194 | 6133 | 46 009 | 50 839 | 34 896 | 62 379 | 18 756 | 26 765 | 39 810 |
| Non-current liabilities | 24 157 | 21 446 | 31 060 | 65 204 | 64 495 | 11 829 | 10 000 | 27 917 | 86 585 | 100 049 | 116 470 |
| Total liabilities | 49 428 | 42 424 | 129 254 | 71 337 | 110 504 | 62 668 | 44 896 | 90 296 | 105 341 | 126 814 | 156 280 |
| Share capital | — | — | — | — | — | — | — | — | — | — | — |
| Retained earnings of previous periods | — | — | — | — | — | — | — | — | — | — | — |
| Profit for the year | -6590 | 7867 | 6208 | 58 965 | -71 143 | 41 987 | 48 290 | 73 533 | 30 146 | -162 113 | -116 078 |
| Total equity | -6490 | 4277 | 10 485 | 69 450 | -1693 | 40 294 | 88 584 | 162 117 | 192 263 | -2707 | -118 785 |
| Income statement | |||||||||||
| Sales revenue | 39 000 | 236 771 | 689 741 | 600 690 | 13 365 | 268 923 | 209 659 | 390 728 | 647 267 | 384 161 | 6861 |
| Operating profit | -6577 | 8104 | 6208 | 58 965 | -71 143 | 41 987 | 48 290 | 73 533 | 30 146 | -162 113 | -116 078 |
| Profit before income tax | -6590 | 8104 | 6208 | 58 965 | -71 143 | 41 987 | 48 290 | 73 533 | 30 146 | -162 113 | -116 078 |
| Profit for the reporting year | -6590 | 7867 | 6208 | 58 965 | -71 143 | 41 987 | 48 290 | 73 533 | 30 146 | -162 113 | -116 078 |
| Labour costs | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation of non-current assets | — | — | — | — | — | — | — | — | — | — | — |
| Other indicators | |||||||||||
| Employees | 1 | 1 | 3 | 1 | 1 | 2 | 2 | 3 | 3 | 3 | 3 |
| Calculated dividend | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 32 857 | 0 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
Click a node to see its other connections.
Related companies
Summary: SIA GriPharma
Overview
SIA GriPharma (reg. no. 50103904871) is a limited liability company. The company was registered in 2015 and has been in the register for 11 years. Registered address: Rīga, Lizuma iela 1 k-12.
Financial results
Revenue in 2025 was 6861 €, down 98,2% on the previous year (384 161 €). From 2015 to 2025, revenue declined by an average of 16,0% per year. This is the company's lowest revenue among the published years (2015–2025). 2025 ended with a loss of 116 078 €. The company was profitable in 7 of the 11 published years. In 2025 the company had 3 employees. Revenue per employee was 2287 €.
Management and owners
The company has one board member. According to the register, the company has 2 owners. The largest stake (60%) is held by a private individual.
Points to note
Equity was negative at the end of 2025 (-118 785 €).
Data sources and freshness
Register data (name, address, legal form, board and owners) and annual report figures come from the open data of the Register of Enterprises of the Republic of Latvia (CC0); entity.lv updates them daily. Data as of 03.11.2026. Changes, averages and ratios are calculated by entity.lv from open data and are not an official assessment.